Skip to main content
SpringerLink
Log in

The role of gene polymorphisms and AMH level in prediction of poor ovarian response in Egyptian women undergoing IVF procedure

  • Genetics
  • Published:
Journal of Assisted Reproduction and Genetics Aims and scope Submit manuscript

Abstract

Objective

The aim of this study is to assess the role of AMH in prediction of poor ovarian response as well as the relation between ESR 2 (+ 1730G>A) (rs4986938) and FSHR p.Thr307Ala (c.919A>G, rs6165) SNPs and the poor ovarian response in Egyptian women undergoing IVF procedure. Discovering the genetic variants associated with ovarian response is an important step towards individualized pharmacogenetic protocols of ovarian stimulation.

Methods

We performed a prospective study on 216 young women with unexplained infertility. Ovarian stimulation was performed according to the GnRH antagonist protocol with a fixed daily morning dose of human menopausal gonadotrophin (HMG). The estrogen receptor (ESR2) (+ 1730G>A) (rs4986938) and FSH receptor p.Thr307Ala (c.919A>G, rs6165) single nucleotide polymorphisms (SNPs) were detected by real-time polymerase chain reaction. Serum FSH, Estradiol (E2) and anti-Müllerian hormone (AMH) levels were measured by enzyme-linked immunosorbent assay (ELISA).

Results

This study revealed that the low AMH level was highly significantly related to the poor ovarian response (p < 0.001). Furthermore, the frequency of the ESR2 (AA) genotype and the FSHR (Ala307Ala) genotypes were highly significantly associated with the poor ovarian response (p < 0.001).

Conclusion

The AMH level in combination with the ESR2 and the FSHR gene polymorphisms predict the poor ovarian response to COH in Egyptian women.

Trial registration

ClinicalTrials.gov Identifier: NCT02640976.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Lledo B, Ortiz JA, Llacer J, Bernabeu R. Pharmacogenetics of ovarian response. Pharmacogenomics. 2014;15:885–93.

    Article  CAS  PubMed  Google Scholar 

  2. Gearhart J, Coutifaris C. In vitro fertilization, the Nobel Prize, and human embryonic stem cells. Cell Stem Cell. 2011;8:12–5.

    Article  CAS  PubMed  Google Scholar 

  3. Macklon NS, Stouffer RL, Giudice LC, Fauser BC. The science behind 25 years of ovarian stimulation for in vitro fertilization. Endocr Rev. 2006;27:170–207.

    Article  PubMed  Google Scholar 

  4. Boudjenah R, Molina-Gomes D, Torre A, Bergere M, Bailly M, Boitrelle F, et al. Genetic polymorphisms influence the ovarian response to rFSH stimulation in patients undergoing in Vitro fertilization programs with ICSI. PLoS One. 2012;7:1–16.

    Article  Google Scholar 

  5. Ubaldi F, Vaiarelli A, D’Anna R, Rienza L. Management of Poor Responders in IVF: is there anything new? Bio Med Research International. 2014;2014:1–10.

    Article  Google Scholar 

  6. Keane K, Cruzat VF, Wagle S, Chaudhary N, Newsholme P, Yovich J. Specific ranges of anti-Mullerian hormone and antral follicle count correlate to provide a prognostic indicator for IVF outcome. Reprod Biol. 2017;17(1):51–9. doi:10.1016/j.repbio.2016.12.002.

    Article  PubMed  Google Scholar 

  7. Broer SL, Broekmans FJ, Laven JS, Fauser BC. Anti-Müllerian hormone: ovarian reserve testing and its potential clinical implications. Hum Reprod Update. 2014;20(5):688–701. doi:10.1093/humupd/dmu020.

    Article  CAS  PubMed  Google Scholar 

  8. Lledo B, Guerrero J, Turienzo A, Ortiz JA, Morales R, Ten J, et al. Effect of follicle-stimulating hormone receptor N680S polymorphism on the efficacy of follicle-stimulating hormone stimulation on donor ovarian response. Pharmacogenet Genomics. 2013;23:262–8.

    Article  CAS  PubMed  Google Scholar 

  9. De Mattos CS, Trevisan CM, Peluso C, Adami F, Cordts EB, Christofolini DM, et al. ESR1 and ESR2 gene polymorphisms are associated with human reproduction outcomes in Brazilian women. Journal of Ovarian Research. 2014;7:1–9.

    Article  Google Scholar 

  10. Altmäe S, Hovatta O, Stravreus-Evers A, Salumets A. Genetic predictors of controlled ovarian hyperstimulation: where do we stand today? Hum Reprod Update. 2011;17(6):813–28.

    Article  PubMed  Google Scholar 

  11. Ochsenkühn R, von Schönfeldt SM. FSH receptor polymorphisms and ovarian function. Med Reprod Gynecol Endocrinol. 2009;11:265–70.

    Google Scholar 

  12. Rod A, Jarzabek K, Wolczynski S, Benhaim A, Reznik Y, Denoual-Ziad C, et al. ESR1 and FSHR gene polymorphisms influence ovarian response to FSH in poor responder women with normal FSH levels. Endocrinol Metab Synd. 2014;3:1–5.

    Google Scholar 

  13. Gleicher N, Weghofer A, Barad DH. Discordances between follicle stimulating hormone (FSH) and anti-Müllerian hormone (AMH) in female infertility. Reprod Biol Endocrinol. 2010;8:64.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Broer SL, D’olleman M, Disseldorp JV, Broeze KA, Opmeer BC, PMM B, et al. Prediction of an excessive response in in vitro fertilization from patient characteristics and ovarian reserve tests and comparison in subgroups: an individual patient data meta-analysis. FertilSteril. 2013;100:420–9.

    Google Scholar 

  15. Vaze-Parab A, Bhatt P, Parihar LM, Baldawa P. Anti-mullerian hormone, follicular phase follicle stimulating hormone and antral follicular count as predictors of ovarian response in assisted reproductive technique cycles. IVF Lite. 2014;1:32–5.

    Article  Google Scholar 

  16. Laan M, Grigorova M, Huhtaniemi IT. Pharamacogenetics of FSH action. Curr Opin Endocrinol Diabetes Obes. 2012;19:220–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Biochemistry, Faculty of Pharmacy, Cairo University, Giza, Egypt

    Tarek M. K. Motawi, Sherine M. Rizk & Nadine W. Maurice

  2. Obstetrics and Gynaecology Department, Cairo University, Giza, Egypt

    Ahmed Mohamed Maged, Ayman N. Raslan & Ahmed H. Sawaf

  3. 135 King Faisal Street Haram, Giza, 12151, Egypt

    Ahmed Mohamed Maged

Authors
  1. Tarek M. K. Motawi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sherine M. Rizk
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Nadine W. Maurice
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ahmed Mohamed Maged
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ayman N. Raslan
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Ahmed H. Sawaf
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ahmed Mohamed Maged.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Funding

There were not any funding sources.

Additional information

Synopsis

The AMH level in combination with the ESR2 and the FSHR gene polymorphisms predict the poor ovarian response to COH in Egyptian women.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Motawi, T.M.K., Rizk, S.M., Maurice, N.W. et al. The role of gene polymorphisms and AMH level in prediction of poor ovarian response in Egyptian women undergoing IVF procedure. J Assist Reprod Genet 34, 1659–1666 (2017). https://doi.org/10.1007/s10815-017-1013-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10815-017-1013-4

Keywords

Search

Navigation